Due to COVID-19, this event has been postponed until further notice. We will be in communication as soon as we have an update. See our Event Terms & Conditions for more information. We are grateful for your cooperation and will keep you informed as the situation evolves. We recognise that these are unsettling times, and we want you to know that the safety of our staff and the TIN community are our priority.
Share this Event
The New Zealand healthcare technology sector had the largest revenue of all TIN-monitored sectors in 2019 with $1.9B and has shown consistent growth with a 5-year CAGR of 9.1%. What is it that makes this sector so successful, and what key lessons and opportunities can the wider tech industry take from the advances of ‘HealthTech’ in New Zealand?
Join us for a light breakfast at our first 2020 TINTalk, Pathways to Success, where Dr. Diana Siew, Associate Director of the MedTech CoRE, and TIN’s Greg Shanahan will present findings from the New Zealand HealthTech Insights Report. Our panel of experts will share their experience and insights on the growth and success of the HealthTech sector and discuss the tools that are available to all NZ tech companies to enable similar results for their respective sectors.
Discussion points will include:
- The secrets to success – and the pitfalls to watch out for – in this highly competitive industry
- Using IP to protect R&D from competitors and making innovation more attractive to investors and partners
- Funding vehicles available
- How to access this funding and what support investors can offer
This event may be photographed and/or filmed. We reserve the right to use any photos or video taken for publication and/or promotional purposes. Please review the full photography & videography disclaimer in the Event Terms & Conditions.
07.00am – Registration and networking, a light breakfast will be served
07.30am – Welcome
07.35am – Greg Shanahan and Diana Siew present key findings from the NZ HealthTech Insights Report
07.50am – Panel discussion followed by Q&A
08.30am – Further networking
09.00am – Close
Cure Kids Ventures Ltd
Maxine is an entrepreneur with more than 30 years biotech industry experience. She serves as an Executive Director for Cure Kids Ventures, a seed and early stage investment fund that invests in the commercialisation of healthcare innovations with potential to benefit child health. Maxine established biotechnology consulting company, BioCatalyst, which advises early stage biotechnology ventures on commercialisation and capital raising.
Maxine has significant private sector and government experience in the biotechnology industry. Her current positions include being a board member of the Maurice Wilkins Centre for Molecular BioDiscovery, an advisory board member of the MedTech Core and director of a number of private companies. She holds a Master of Science degree in biological sciences from the University of Auckland, is a chartered member of the NZ Institute of Directors and was recently appointed a Companion of the NZ Order of Merit for her services to science, particularly biotechnology.
James and Wells
Jonathan is a leading trans-Tasman patent attorney, heading James & Wells’ Auckland and Hamilton Patents Teams, as well as its specialist medical technology team. He provides strategic advice to many local and multi-national companies on all aspects of intellectual property, particularly specialising in patents.
Jonathan’s strong academic background in physics has formed the basis for his expertise in a range of technologies, including the med-tech sector. He is an Associate member of the Medical Technology Association of New Zealand (MTANZ) and provides regular seminars educating the New Zealand med-tech industry on the value of intellectual property.
Managing Director and Founder
Brian has held senior corporate roles in life sciences and health care companies over the last 20 years.
He is a graduate from Massey University with a Bachelor’s degree in Veterinary Science, a Member of the Royal College of Veterinary Surgeons (UK), and holds a Masters degree in Business Administration graduating with distinction. He has extensive management experience in life science companies spanning clinical, technical, sales, marketing, corporate development and strategy having worked for a number of multinationals including Baxter, Beecham and SmithKline Beecham throughout the world. He has managed investments into New Zealand technology companies for the Foundation for Research Science and Technology, served as the founding CEO of NZBio, and has sat on a number of government and industry expert panels.
Brian was the Founder of Aroa (previously Mesynthes) and has been responsible for leading the company’s growth from start-up through to becoming a vertically integrated medical device business with substantial US sales and a developing international presence.
Diana Siew’s role in the NZ Innovation environment is to support and help develop New Zealand’s medical technology sector to grow the economy through partnerships and collaborations between firms, researchers, clinicians and government through two national initiatives.
Diana co-chairs the CMDT and is an Associate Director of the MedTech Centre of Research Excellence (MedTech CoRE), responsible for strategy and industry relationships.
She is also Strategic Partnership lead at the Auckland Bioengineering Institute, a Director of AI medical device start up, Toku Eyes and sits on the Return on Science MedicalTech and Surgery Investment Committee.
Save 25% on TINTalk Tickets
And receive your 2020 TIN Report at no extra cost
Additionally, you'll gain opportunities to increase your company's profile through exposure in the TINTech Directory, the fortnightly TINWire, and across TIN's social media channels. We'll also keep you up to date on the pulse of the NZ tech sector with meaningful insights from TIN's proprietary database that will help you to enhance your company's performance.